CLINICAL RESEARCH: VALVULAR HEART DISEASE
Dysregulation of Antioxidant Mechanisms Contributes to Increased Oxidative Stress in Calcific Aortic Valvular Stenosis in Humans
Jordan D. Miller, PhD*,*,
Yi Chu, PhD*, ,
Robert M. Brooks, BS*,
Wayne E. Richenbacher, MD ,
Ricardo Peña-Silva, MD*, and
Donald D. Heistad, MD*, ,
* Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa
Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, Iowa
Department of Cardiothoracic Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa
Veterans Affairs Medical Center, Iowa City, Iowa
Manuscript received November 12, 2007;
revised manuscript received May 1, 2008,
accepted May 27, 2008.
* Reprint requests and correspondence: Dr. Jordan D. Miller, University of Iowa, Department of Internal Medicine, 200 Hawkins Drive, Iowa City, Iowa 52242 (Email: jordan-miller{at}uiowa.edu).
Objectives: The aim of this study was to determine whether oxidative stress is increased in calcified, stenotic aortic valves and to examine mechanisms that might contribute to increased oxidative stress.
Background: Oxidative stress is increased in atherosclerotic lesions and might play an important role in plaque progression and calcification. The role of oxidative stress in valve disease is not clear.
Methods: Superoxide (dihydroethidium fluorescence and lucigenin-enhanced chemiluminescence), hydrogen peroxide (H2O2) (dichlorofluorescein fluorescence), and expression and activity of pro- and anti-oxidant enzymes were measured in normal valves from hearts not suitable for transplantation and stenotic aortic valves that were removed during surgical replacement of the valve.
Results: In normal valves, superoxide levels were relatively low and distributed homogeneously throughout the valve. In stenotic valves, superoxide levels were increased 2-fold near the calcified regions of the valve (p < 0.05); noncalcified regions did not differ significantly from normal valves. Hydrogen peroxide levels were also markedly elevated in calcified regions of stenotic valves. Nicotinamide adenine dinucleotide phosphate oxidase activity was not increased in calcified regions of stenotic valves. Superoxide levels in stenotic valves were significantly reduced by inhibition of nitric oxide synthases (NOS), which suggests uncoupling of the enzyme. Antioxidant mechanisms were reduced in calcified regions of the aortic valve, because total superoxide dismutase (SOD) activity and expression of all 3 SOD isoforms was significantly decreased. Catalase expression also was reduced in pericalcific regions.
Conclusions: This study provides the first evidence that oxidative stress is increased in calcified regions of stenotic aortic valves from humans. Increased oxidative stress is due at least in part to reduction in expression and activity of antioxidant enzymes and perhaps to uncoupled NOS activity. Thus, mechanisms of oxidative stress differ greatly between stenotic aortic valves and atherosclerotic arteries.
Key Words: aortic valve calcification oxidative stress stenosis
|
Abbreviations and Acronyms
| | DHE = dihydroethidine | | L-NAME = nitro-L-arginine methyl ester | | mRNA = messenger ribonucleic acid | | NADPH = nicotinamide adenine dinucleotide phosphate | | NOS = nitric oxide synthase | | SOD = superoxide dismutase |
|
Related Articles
-
Oxidation, Inflammation, and Aortic Valve Calcification: Peroxide Paves an Osteogenic Path
- Dwight A. Towler
J. Am. Coll. Cardiol. 2008 52: 851-854.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A31-A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Almeida, E. Ambrogini, L. Han, S. C. Manolagas, and R. L. Jilka
Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-{gamma} Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton
J. Biol. Chem.,
October 2, 2009;
284(40):
27438 - 27448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Pena-Silva, J. D. Miller, Y. Chu, and D. D. Heistad
Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves
Am J Physiol Heart Circ Physiol,
October 1, 2009;
297(4):
H1354 - H1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Owens and C. M. Otto
Is it Time for a New Paradigm in Calcific Aortic Valve Disease?
J. Am. Coll. Cardiol. Img.,
August 1, 2009;
2(8):
928 - 930.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Koleganova, G. Piecha, E. Ritz, P. Schirmacher, A. Muller, H.-P. Meyer, and M.-L. Gross
Arterial calcification in patients with chronic kidney disease
Nephrol. Dial. Transplant.,
August 1, 2009;
24(8):
2488 - 2496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Miller, R. M. Weiss, K. M. Serrano, R. M. Brooks II, C. J. Berry, K. Zimmerman, S. G. Young, and D. D. Heistad
Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice
Circulation,
May 26, 2009;
119(20):
2693 - 2701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, P. Biglioli, E. Tremoli, and F. Alamanni
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Eur. J. Cardiothorac. Surg.,
March 1, 2009;
35(3):
493 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008.
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pazianas, A. B. Rossebo, T. R. Pedersen, Y. A. Kesaniemi, and C. M. Otto
Calcific Aortic Stenosis
N. Engl. J. Med.,
January 1, 2009;
360(1):
85 - 86.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Towler
Oxidation, Inflammation, and Aortic Valve Calcification: Peroxide Paves an Osteogenic Path
J. Am. Coll. Cardiol.,
September 2, 2008;
52(10):
851 - 854.
[Full Text]
[PDF]
|
 |
|
|